We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Pramiracetam
A racetam-class nootropic structurally related to piracetam, promoted for memory and focus. Honest appraisal: the human evidence is very thin — essentially a couple of small, decades-old studies (one positive in head-injury patients, one largely unconvincing in Alzheimer's) plus a lot of anecdote. No modern, well-powered trials in healthy people.
What the evidence says
Most Pramiracetam studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality randomised trials published 1991–1994 with a typical study size of 10 participants.
Based on 3 studies · 2 RCTs · 10 total participants
Confidence
LowBy outcome
Pramiracetam has an evidence score of 2.5/10 — emerging evidence based on 3 indexed studies. A racetam-class nootropic structurally related to piracetam, promoted for memory and focus. Honest appraisal: the human evidence is very thin — essentially a couple of small, decades-old studies (one positive in head-injury patients, one largely unconvincing in Alzheimer's) plus a lot of anecdote. No modern, well-powered trials in healthy people. Representative study: PMID 1786500.
The commonly studied dose of Pramiracetam is Commonly 400-1200mg/day in divided doses (no robustly validated regimen). Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Explore: Best supplements for Focus, Memory & Mood
Last reviewed June 2026 · evidence from 3 studies · how we score
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Pramiracetam is a member of the racetam family (relatives of piracetam) marketed as a cognitive enhancer for memory and concentration. Its proposed mechanism is poorly defined: like other racetams it lacks affinity for classical neurotransmitter receptors, and effects are attributed vaguely to enhanced hippocampal high-affinity choline uptake and potentiation of existing neurotransmission rather than any single well-characterized target. The honest evidence picture is weak. The most-cited human result is a small 1991 double-blind placebo-controlled study in young men with memory deficits after head injury/anoxia, which reported clinically significant improvement in delayed recall. A 1991 enrichment-design trial in 10 Alzheimer's patients was largely unconvincing — only 2 of 8 'best-dose' responders replicated, and the authors concluded benefit in Alzheimer's was unlikely. Beyond these and a few comparative reviews, there is essentially no modern, adequately-powered randomized evidence — particularly none in healthy adults seeking cognitive enhancement. Most popular claims are anecdotal. The overall evidence is therefore low/emerging.
Proposed to enhance high-affinity choline uptake in the hippocampus, indirectly supporting cholinergic/memory function.
Like other racetams, thought to modulate ion flux and potentiate already-present neurotransmission rather than bind a specific receptor.
How Pramiracetam works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Tap node to isolate • Pinch to zoom • Tap edge for research
Commonly 400-1200mg/day in divided doses (no robustly validated regimen)
Take with food
| Form | Type |
|---|---|
| 💊Pramiracetam | Recommended |
| 💊Piracetam | Alternative |
Piracetam is the parent racetam with a larger (though still modest) evidence base; pramiracetam's human data are thinner.
Compare Pramiracetam vs Piracetam →Minimum: 4 weeks
Optimal: 8 weeks
Cycling: Not required
Note: Divided doses earlier in the day; many users co-administer a choline source to offset headache.
Dose-response data unavailable. The current published research for Pramiracetam does not provide sufficient dose-specific outcome data to generate reliable dose-response curves.
Refer to the Dosage & Timing section above for recommended dose ranges based on available evidence.
Improved delayed recall reported in head-injury patients in one small trial.
Cognitive-enhancement claims in healthy people are anecdotal — no controlled trials.
A small enrichment-design trial found benefit in Alzheimer's unlikely.
Use caution — racetams are renally cleared.
Use caution due to theoretical platelet effects.
Not studied — avoid.
Racetams have been associated with effects on platelet aggregation; theoretical additive bleeding risk — use caution.
Racetams' cholinergic-leaning activity could be additive with cholinesterase inhibitors or other cholinergics.
Tip: Add a choline source (e.g. citicoline/alpha-GPC); reduce dose
Tip: Lower dose; dose earlier in the day
Tip: Avoid late-day dosing
Tip: Take with food
Racetams can deplete/demand choline; citicoline supplies choline and may reduce racetam-associated headaches while supporting acetylcholine synthesis.
Choline co-supply to support the cholinergic rationale and reduce headache.
A high-bioavailability choline source commonly paired with racetams for the same headache-mitigation and acetylcholine-support reasons.
Cholinergic support to complement pramiracetam (both modestly evidenced).
The best time to take Pramiracetam is in the morning. Take it with food. Often taken in two or three divided doses earlier in the day; the head-injury trial used 400 mg three times daily.
Pramiracetam is generally safe at recommended doses, with a few precautions worth noting. The most commonly reported side effects are headache, nervousness / agitation, insomnia. Use caution if any of these apply to you: Pregnancy/breastfeeding (not studied); Severe kidney impairment (renal clearance); Known hypersensitivity to racetams.
Crosses the blood-brain barrier to fuel acetylcholine synthesis — supports focus, memory, and power output in athletes.